For example, TAAR1 agonists modulate presynaptic pathways and regulate dopamine- and glutamatergic neurotransmission in schizophrenia, also reducing negative symptoms and improving cognitive functions in rodent and primate models of this disorder [142]. Here, TAAR1 is linked to schizophrenia.